Our Perspectives

GLP-1

With our experience comes a unique perspective. Hear what we have to say.

Working across the globe, we capture a particular point of view on what matters in CPG both today and in the future. Read our original considerations on trending topics.

, 25 January 2025

The “Ripple Effect”: Why Ozempic’s Impact on the CPG Industry is a Slow-Burning Disruption

GLP-1s – originally intended to treat diabetes, are designed to mimic the way a hormone called glucagon-like peptide 1 works... View Article

Colin McAllister

Sevendots, Milan

Gabrielle Carruthers

Sevendots, London